Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
11%
OVERLAP
BY WEIGHT
48
# OF OVERLAPPING
HOLDINGS
VHT
410
HOLDINGS
12%
ALSO IN XPH
XPH
55
HOLDINGS
89%
ALSO IN VHT
SECTOR DRIFT (VHT minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.2% | 1.9% | 1.9% |
|
MERCK & CO. INC. | 4.5% | 1.8% | 1.8% |
|
BRISTOL-MYERS SQUIBB CO | 1.9% | 1.8% | 1.8% |
|
JOHNSON & JOHNSON | 8.8% | 1.7% | 1.7% |
|
PFIZER INC | 2.4% | 1.7% | 1.7% |
VHT Overweight Relative to XPH
|
ELI LILLY & CO | 11.3% |
|
JOHNSON & JOHNSON | 7.1% |
|
ABBVIE INC | 6.1% |
|
UNITEDHEALTH GROUP INC | 5.8% |
|
AMGEN INC | 2.9% |
|
MERCK & CO. INC. | 2.7% |
|
THERMO FISHER SCIENTIFIC INC | 2.7% |
|
GILEAD SCIENCES INC | 2.6% |
|
INTUITIVE SURGICAL INC | 2.4% |
|
ABBOTT LABORATORIES | 2.4% |
VHT Underweight Relative to XPH
|
ORGANON & CO. | -3.8% |
|
CORCEPT THERAPEUTICS INC | -3.0% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.7% |
|
AXSOME THERAPEUTICS, INC. | -2.5% |
|
ENLIVEN THERAPEUTICS, INC. | -2.5% |
|
TREVI THERAPEUTICS, INC. | -2.2% |
|
ESPERION THERAPEUTICS INC | -2.1% |
|
ROYALTY PHARMA PLC CLASS A | -2.1% |
 |
JAZZ PHARMACEUTICALS PLC | -2.1% |
|
DEFINIUM THERAPEUTICS INC | -2.1% |